ARTICLE | Company News
Bayer submits MAA for radium-223 for CRPC
December 13, 2012 2:25 AM UTC
Bayer AG (Xetra:BAYN) submitted an MAA to EMA for radium-223 dichloride (formerly Alpharadin) to treat castration-resistant prostate cancer (CRPC) in patients with bone metastases. The submission trig...